Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Therapeutic Target
100%
AKT3
100%
Melanoma
100%
Melanoma Patients
36%
B-Raf
27%
V600E
27%
Effective Therapy
18%
Quality of Life
18%
Length of Life
18%
Positive Impact
18%
Tumorigenesis
18%
Combinatorial Approach
18%
Signaling Pathway
18%
Isothiocyanates
18%
Poor Prognosis
9%
Therapeutic Approaches
9%
Skin Cancer
9%
Therapeutic Potential
9%
Advanced Disease
9%
Poor Survival
9%
Isoselenocyanates
9%
Chemoresistance
9%
Synthetic Compounds
9%
Therapeutic Agents
9%
Malignant Melanoma
9%
Clinical Trials
9%
Chemopreventive
9%
Advanced Stage
9%
Apoptosis
9%
Term Discovery
9%
Metastasis
9%
Therapeutic Implications
9%
Survival Rate
9%
Effective Approach
9%
Combinational Therapy
9%
Unanswered Questions
9%
Medicine and Dentistry
Melanoma
100%
Quality of Life
12%
Carcinogenesis
12%
Diseases
12%
Cell Signaling Pathway
12%
Therapeutic Agent
6%
Survival Rate
6%
Programmed Cell Death
6%
Clinical Trial
6%
Metastatic Carcinoma
6%
Isothiocyanic Acid
6%
Drug Resistance
6%
Skin Cancer
6%
Isothiocyanic Acid Derivative
6%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Carcinogenesis
12%
Isothiocyanate
12%
Diseases
12%
Clinical Trial
6%
Survival Rate
6%
Drug Resistance
6%
Skin Cancer
6%